Ripca Pharmaceutical Private Limited

Ripca Pharmaceutical Private Limited - pharma in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24100MP2022PTC072237 Incorporated 17 February 2022 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma Startup India MSME · Micro
Revenue · FY 2024
₹59.22 Lakh
▲ 161% YoY
Net profit · FY 2024
₹53,423
Net margin 0.9%
EBITDA · FY 2024
₹85,656
EBITDA margin 1.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ripca Pharmaceutical Private Limited

Data last updated:

Ripca Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2022.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2022PTC072237.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saleem Malik Ansari and Rachna Vaish.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2024, the company reported a revenue of ₹59.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹53,423 (net margin 0.9%) and EBITDA of ₹85,656 (EBITDA margin 1.4%).

Ripca Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0049865).

Company details

CIN U24100MP2022PTC072237
Registration Number 072237
Incorporation Date 17 February 2022
ROC Gwalior
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0049865

CIN history

Ripca Pharmaceutical has one previous CIN (Corporate Identification Number): U24100GJ2022PTC129439. The current CIN is U24100MP2022PTC072237, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100MP2022PTC072237Current
U24100GJ2022PTC129439Previous

Recognitions & Rankings of Ripca Pharmaceutical

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-24-0049865

Contact details

Ripca Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh.

  • Registered Address
    Ed – 200 Ground Floor, Scheme No 94 Ring Road, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Ripca Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ripca Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ripca Pharmaceutical Private Limited, buy the company report.

Financials of Ripca Pharmaceutical Private Limited

FY 2025 filings available

Ripca Pharmaceutical Private Limited reported revenue of ₹59.22 Lakh (up 161% YoY) for FY 2024.

Revenue · FY 2024
₹59.22 Lakh ▲ 161%
Net profit · FY 2024
₹53,423 margin 0.9%
EBITDA · FY 2024
₹85,656 margin 1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 161%
EBITDA CAGR growth
1 year
▲ 212%

Revenue rose 161% in the latest year. EBITDA rose 212% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹85,656
Profit Before Tax
Tax Expense
Net Profit (PAT)₹53,423
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.4%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ripca Pharmaceutical Private Limited, buy the company report.

Board of directors of Ripca Pharmaceutical Private Limited

Ripca Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saleem Malik AnsariDirector20 Nov 20233 Years 0 MonthsCurrent
Rachna VaishDirector17 Feb 20224 Years 9 MonthsCurrent

Peer comparison

Ripca Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Xania Lifescience Private Limited₹59.42 Lakh (FY 2025)13.0%Ahmedabad, Gujarat, India
Malik Perfume Private Limited₹59.39 Lakh (FY 2025)-88.0%Kannauj, Uttar Pradesh, India
Liladhar Biyani Saltpetre (India) Limited₹59.33 Lakh (FY 2025)36.0%Rajasthan, India
Agatsya Aushadh Private Limited₹59.31 Lakh (FY 2024)89.0%Bangalore, Karnataka, India
Ceramond India Private Limited₹59.3 Lakh (FY 2020)115.0%Adarsh Nagar, New Delhi, Delhi, India
Ripca Pharmaceutical Private Limitedthis company₹59.22 Lakh (FY 2024)₹53,4230.9%161.0%Indore, Madhya Pradesh, India
GHK Organics Private Limited₹59.16 Lakh (FY 2025)598.0%Jhagadia, Gujarat, India
Super Petroleum Products Private Limited₹59.11 Lakh (FY 2025)-25.0%Thane, Maharashtra, India
Decro Colors Private Limited₹59.1 Lakh (FY 2024)-52.0%Ahmedabad, Gujarat, India
Chemotech Industries India Private Limited₹59.09 Lakh (FY 2023)36.0%Dombivli, Maharashtra, India
Dandraua Dhaam Private Limited₹59.08 Lakh (FY 2025)89.0%Gwalior, Madhya Pradesh, India

To see the full peer comparison of Ripca Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ripca Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ripca Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ripca Pharmaceutical Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Saleem Malik Ansari ceased to be Additional Director on 29 Sep 2024.

AGM
Ripca Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ripca Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Saleem Malik Ansari ceased to be Additional Director.
Ceased
Kamlesh Rathore ceased to be Additional Director.
Ceased
Sangita ceased to be Director.
Appointed
Saleem Malik Ansari was appointed as Director.
Ceased
Manisha Rathore ceased to be Additional Director.
Appointed
Rachna Vaish was appointed as Director.
Incorporation
17 Feb 2022
Ripca Pharmaceutical Private Limited was registered on 17 Feb 2022 with Roc Gwalior & aged 4 years 9 months as per MCA records.

Frequently asked questions

Ripca Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2022 (4+ years old) and is registered under CIN U24100MP2022PTC072237.

Ripca Pharmaceutical has 2 current directors:

The latest financial statements of Ripca Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Ripca Pharmaceutical is U24100MP2022PTC072237. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ripca Pharmaceutical was incorporated on 17 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Ripca Pharmaceutical by revenue are Xania Lifescience Private Limited, Malik Perfume Private Limited, Liladhar Biyani Saltpetre (India) Limited, Agatsya Aushadh Private Limited, Ceramond India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Saleem Malik Ansari ceased to be Additional Director on 29 Sep 2024. Kamlesh Rathore ceased to be Additional Director on 10 Jul 2024. Sangita ceased to be Director on 04 Mar 2024. Ripca Pharmaceutical has 6 board changes on record in total.

Yes, Ripca Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Ripca Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0049865).

The registered office of Ripca Pharmaceutical is at Ed – 200 Ground Floor, Scheme No 94 Ring Road, Indore, Madhya Pradesh, India – 452001.

Ripca Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.